I will comment on that.
First of all, this issue was not raised at all in the second panel. It was raised in the first panel. Frankly, as the chair, I let questions go that in my view were not related to the study before the committee. The committee is supposed to study an overview of Canadian science and technology policy. My hope in having groups here like the Generic Association and Rx & D was to comment on science and technology in general, not to comment on regulations that are proposed by the government with respect to a specific industry. I would argue that the questions actually almost exceeded that, so I would argue it's not related to the study we're doing with respect to Canadian science and technology.
I've made my ruling with respect to the need for 48 hours or unanimous consent. That's my decision.